Weight Loss Artelo Biosciences Completes Enrollment of the First Three Cohorts in its CAReS Study Evaluating ART27.13 for the Treatment of Cancer-Related Anorexia and Weight LossBy adminJuly 19, 20220 Solana Beach, CA, July 19, 2022 (GLOBE NEWSWIRE)-Artelo Biosciences, Inc. (Nasdaq: ARTL), A clinical-stage pharmaceutical company focused on regulating lipid…
